Cannabis for Pediatric Chronic Pain Management
Learning Objectives
- Describe the biological vulnerabilities of the the developing brain in children and adolescents when exposed to regular cannabis use.
- Discuss specific mental health diagnoses that may more prevalent in children or adolescents exposed to regular use of cannabis.
- Review current literature supporting evidence for the use of cannabis for pediatric chronic
Dr. Deepa Kattail, Anaesthesiologist, McMaster Children’s Hospital – Hamilton Health Sciences
Deepa Kattail is a pediatric anesthesiologist and chronic pain physician at McMaster Children’s Hospital as well as assistant professor in the Faculty of Health Sciences. She also serves as the director of the pediatric anesthesia fellowship program. She is actively involved in the Society of Pediatric Pain Medicine, recently elected to the board of directors and is co-chair for the knowledge and translation committee for the Ontario Chronic Pain Network.
Resources Mentioned in Session
- Review: Treatment of complex regional pain syndrome type I with bisphosphonates
- The endocannabinoid system and its therapeutic exploitation
- Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions
- Cannabinoids in Pediatrics
- Cannabis and Canada’s Children & Youth
- Drug Use Among Ontario Students
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome
- Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis
Next Session
May 23, 2025
11:00 am – 12:00 pm
Psychological treatments for chronic pain
Register